NCT06905002Recruiting
Enhancing the Patient Journey to Clinical Trial Enrolment With Navigation to Optimize Accrual
Enhancing the Patient Journey to Clinical Trial Enrolment With Navigation to Optimize Accrual: A Pilot Study for a Prospective, Pragmatic Multi-centre, Stepped Wedge, Cluster Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
Less than 5% of patient enter clinical trials, despite the fact that many patients facing cancer are recommended to seek out clinical trials. One challenge of finding a clinical trial, is the lack of clinical trials at the patient's home cancer centre. The Clinical Trials Navigator (CTN) program was established to help patients, their families and heath care providers navigate the clinical trials systems across Canada in order to identify meaningful clinical trials for patients and help them enter those trials. The CTN program was piloted in Windsor, Ontario and increased clinical trials accrual for this population by 8%. This study plans to roll out to twenty centres across Canada, mimicing the process. This implementation of the CTN program will be tested by adding centres in a sequential fashion until all centres are added over the 12 month period. The objectives are improved patient enrollment which will be measured by embedded CTNs in each cancer centre, and reporting to the central site. Pre- and post-implementation structured interviews with administrators, physicians, patients and allied health care professionals will be used to assess uptake of the CTN program in each centre and reveal potential barriers to successful implementation of a nation-wide CTN program. The ability of the current CTN program to upscale to twenty centres will be measured by turn-around times of patient reports and through the structured interviews.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 17 Mar 2025
- Start date
- 1 Apr 2025
- Primary completion date
- Jul 2028
- Lead sponsor
- Windsor Regional Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT06905002
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 1 Apr 2025 to the primary completion date, Jul 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- People outside of these two expansion sites
Who the study is looking for
- Limited to Thunder Bay and Winnipeg health care professionals and patients;
Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thunder Bay Regional Health Sciences Centre Coordinator of this site? Confirm its status | Thunder Bay | Canada | Recruiting |
| Windsor Regional Hospital Coordinator of this site? Confirm its status | Windsor | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.